Chemplast Sanmar Limited has informed the Exchange regarding 'Outcome of Board Meeting - No dividend was recommended by the Board for the financial year ended 31st March, 2025'.
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemplast Sanmar's Board approved audited standalone and consolidated results for Q4 and FY ended 31 March 2025. Consolidated revenue grew about 11% YoY to Rs 4,346.07 crores, while consolidated net loss narrowed to Rs 54.17 crores from Rs 110.36 crores in FY24. Standalone revenue surged 44% to Rs 2,387.61 crores with a much smaller loss of Rs 25.21 crores (vs Rs 52.30 crores in FY24). A revaluation gain of Rs 417.89 crores on property, plant and equipment was recognized in other comprehensive income. The Board did not recommend any dividend for FY25. Statutory auditor BSR & Co. LLP issued an unmodified (clean) opinion on the results. Mr Vikram Taranath Hosangady was appointed as Non-Executive Independent Director for 5 years, and B Ravi and Associates was appointed as Secretarial Auditor for FY26–FY30. The 41st AGM is scheduled for 7 August 2025.
No dividend is a disappointment for income investors, but the sharp YoY drop in losses and strong standalone revenue growth (44%) signal improving operations. However, the company is still loss-making at both standalone and consolidated levels, so profitability recovery remains the key trigger for any sustained re-rating.